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Membrane penetration of nonenveloped viruses is a
poorly understood process. We have investigated
early stages of this process by studying the confor-
mational change experienced by polyomavirus (Py) in
the lumen of the endoplasmic reticulum (ER), a step
that precedes its transport into the cytosol. We show
that a PDI-like protein, ERp29, exposes the C-terminal
arm of Py’s VP1 protein, leading to formation of a hy-
drophobic particle that binds to a lipid bilayer; this
reaction likely mimics initiation of Py penetration
across the ER membrane. Expression of a dominant-
negative ERp29 decreases Py infection, indicating
ERp29 facilitates viral infection. Interestingly, cholera
toxin, another toxic agent that crosses the ER mem-
brane into the cytosol, is unfolded by PDI in the ER.
Our data thus identify an ER factor that mediates
membrane penetration of a nonenveloped virus and
suggest that PDI family members are generally in-
volved in ER remodeling reactions.
Introduction
Viruses must overcome numerous host-cell barriers to
deliver their nucleic acid into the cytosol or nucleus to
cause infection. One critical barrier is the complex
membranous system surrounding and residing within
the host cell. Depending on the penetration site (i.e.,
the plasma membrane or an intracellular membrane),
viruses have devised unique strategies to breach this
barrier (Smith and Helenius, 2004). These strategies are
dictated by the nature of the viral structure itself along
with the particular cellular conditions (e.g., pH, redox,
and cellular factors) that exist at the penetration site.
A critical structural feature regulating their membrane*Correspondence: btsai@umich.edu
4 These authors contributed equally to this work.transport process is the presence or absence of an en-
velope surrounding the virus.
Penetration of enveloped viruses across a membrane
has been well characterized; virally encoded hydropho-
bic “fusion peptides” embedded within the envelope
become exposed in response to a triggering event, pro-
moting the fusion of the viral and cellular membrane
(Poranen et al., 2002). Consequently, the viral nucleo-
protein complex is delivered de facto across the cellu-
lar membrane. For example, influenza virus is first taken
up by endocytosis into endosomal compartments
where the low pH environment triggers the exposure of
a hydrophobic peptide buried within the viral mem-
brane (Skehel and Wiley, 2000); the hydrophobic pep-
tide stimulates fusion of the viral and endosomal mem-
brane, thereby delivering the viral nucleocapsid into
the cytosol.
However, nonenveloped viruses such as the murine
polyomavirus (Py) and SV40 must have a fundamentally
different membrane penetration mechanism than that
of enveloped viruses because nonenveloped viruses
lack a lipid bilayer. Although direct experimental data is
sparse (Fricks and Hogle, 1990; Chandran et al., 2002),
these viruses are thought to cross biological mem-
branes by interacting with cellular cues (e.g., receptors,
proteases, chaperones) that impart conformational
changes and render the viruses hydrophobic. The hy-
drophobic viral particles then penetrate the membrane
by locally inducing “pores” in the lipid bilayer. The
physiological factors that induce the conformational
changes to the nonenveloped viruses and how the re-
modeling reactions facilitate their membrane penetra-
tion have been poorly characterized to date.
We focused our study on the molecular mechanisms
by which Py penetrates a cellular membrane. Structur-
ally, the Py capsid is made up of 72 pentamers of the
major structural protein VP1, with each VP1 extending
its long C-terminal arm to adjacent pentamers to stabi-
lize interpentamer interactions (Stehle et al., 1994).
Each VP1 pentamer also binds to an internal VP2 or
VP3 protein through hydrophobic interactions (Chen et
al., 1998). The VP2 and VP3 proteins overlap in se-
quence and differ only at their N terminus, where the
longer VP2 protein contains a myristic acid (Streuli and
Griffin, 1987). The viral DNA is in turn packaged within
the virus.
To infect cells, Py and SV40 bind to glycolipid recep-
tors called ganglioside GD1a and GM1, respectively, on
the host cell’s plasma membrane (Tsai et al., 2003; Gil-
bert and Benjamin, 2004). The viruses are subsequently
transported to the endoplasmic reticulum (ER) lumen
(Kartenbeck et al., 1989; Pelkmans et al., 2001; Tsai et
al., 2003). Transport to the ER is essential, as treatment
of cells with brefeldin A (a drug that interferes with traf-
ficking between the ER and Golgi) blocks Py and SV40
infection (Richards et al., 2002; Gilbert and Benjamin,
2004). From this compartment, these viruses are be-
lieved to penetrate the ER membrane in order to reach
the cytosol (Norkin et al., 2002; Pelkmans and Helenius,
2003). Although it is possible that Py is transported di-
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brane is continuous with the nuclear membrane), evi-
dence shows that SV40 is transported into the cytosol
prior to reaching the nucleus (Nakanishi et al., 1996).
Subsequent transport of the virus to the nucleus en-
ables transcription and replication of the viral DNA,
leading to lytic infection or cell transformation.
Although the molecular mechanism of Py transport
from the ER into the cytosol remains undefined, impor-
tant insights may be drawn from other pathogens that
hijack cellular factors in their efforts to breach the ER
membrane. The best example is the transport of cho-
lera toxin (CT) across the ER membrane. To intoxicate
cells, CT travels from the plasma membrane to the ER,
where it is unfolded by the ER oxido-reductase protein
disulfide isomerase (PDI) (Tsai et al., 2001). This step
prepares the toxin for transport across an ER mem-
brane channel (Schmitz et al., 2000) to reach the cyto-
sol, where it exerts its cytotoxic effect. We postulate
that Py, analogous to CT transport, would experience a
conformational change in the ER to initiate its transport
across the ER membrane. However, because Py is sig-
nificantly larger than CT (450 Å versus 60 Å in diameter),
Py is unlikely to pass though a protein-conducting
channel in the ER membrane. How the virus is trans-
ported across the ER membrane subsequent to the
structural changes is completely unknown.
Here, we clarify the early stages of Py’s membrane
transport process by identifying ERp29, an ER resident
protein structurally related to PDI (Mkrtchian et al.,
1998), as a factor essential in exposing the VP1 C-ter-
minal arm in the ER. This reaction leads to the forma-
tion of a hydrophobic viral particle that binds to a lipid
bilayer, a step that may prepare the virus for transport
directly across the ER membrane. In the intact cell,
overexpression of the dominant-negative ERp29 N-ter-
minal domain (NTD) that blocked the Py conformational
change in vitro concomitantly decreased Py infection,
implicating ERp29 as a critical component in the viral
infection pathway. Our data thus identify an ER factor
that mediates membrane penetration of a nonenve-
loped virus and suggest that PDI family members are
generally involved in ER remodeling reactions.
Results
ER Activity Triggers a Conformational Change in Py
To determine whether the Py virion undergoes a confor-
mational change in the ER, intact Py particles were in-
cubated with an extract containing ER lumenal proteins
derived from dog pancreas (henceforth referred to as
lumenal extract) under conditions similar to those pre-
viously defined for the study of CT unfolding (Tsai et
al., 2001). Conformational changes were detected by
monitoring the pattern of digestion products after treat-
ment with trypsin. When particles of the small plaque
RA strain of Py were incubated with trypsin, partial di-
gestion of the VP1 protein was seen (Figure 1A, com-
pare lane 2 to lane 1). Incubation of the virus with the
reducing agent dithiothreitol (DTT) and the calcium
chelator EGTA generated a specific band of approxi-
mately 40 kDa (called “VP1a”) after trypsin addition




























































e incubated Py in the presence of DTT, EGTA, and a
umenal extract followed by trypsin addition, a distinct
and of approximately 38 kDa (named “VP1b”) ap-
eared (Figure 1A, compare lane 16 to lane 15). This
ragment was also seen when Py was incubated with a
umenal extract and either DTT (Figure 1A, lane 12) or,
o a lesser extent, EGTA alone (Figure 1A, lane 14). In-
ubation of the more tumorigenic large plaque PTA
train of Py with a lumenal extract, DTT, and EGTA fol-
owed by trypsin addition also induced the appearance
f the VP1b peptide (Figure 1B, compare lane 8 to lane
). Because a mouse is Py’s natural host, we tested
hether exposure of Py virions to an ER lumenal ex-
ract derived from mouse pancreas generates the VP1b
ragment and found that it does (Figure 1C, lane 3). We
onclude that an ER activity efficiently alters the con-
ormation of Py VP1.
To identify the trypsin-cleavage site in VP1 that gen-
rates the VP1b fragment, VP1 and VP1b were isolated
nd subjected to mass-spectrometry. A C-terminal
ryptic fragment (residues 353–368) is absent in VP1b.
o tryptic fragments were found to match the N termi-
us of either VP1 or VP1b. Due to the many lysine and
rginine residues at the N terminus of VP1, tryptic frag-
ents generated from this region would be very small
nd, hence, undetectable using mass-spectrometry.
hese findings indicate that ER activity minimally ex-
oses the VP1 C-terminal arm. Whether the N terminus
f VP1 is also exposed remains unknown. Because
-ray structural studies previously demonstrated that
he VP1 C-terminal arms invade neighboring pentamers
o stabilize the virion structure (Figure 1D, Stehle et al.,
994), externalization of the C-terminal arm by the ER
ctivity would likely destabilize the virus.
The ER activity is energy independent, as the VP1b
ragment was generated in the absence of ATP (Figure
, compare lane 4 to lane 6), but it is heat-labile (Figure
, lane 8). Confirming our hypothesis that the structural
hange experienced by Py is an ER-specific event, the
ctivity was present in a lumenal, but not a cytosolic,
xtract (Figure 2, compare lane 10 to lanes 6 and 4).
he lumenal extract was not measurably contaminated
ith cytosolic proteins or vice versa, as the ER protein
DI was present only in the lumenal extract and the
ytosolic protein Hsp90 only in the cytosolic extract
Figure 2, compare lane 11 to lane 12).
Rp29 Triggers the Conformational Change in Py
ased on initial studies showing that ER activity was
ot retained by a concanavalin A column and that it
as retained by a strong, but not a weak, anion ex-
hange column, we devised a purification scheme out-
ined in Figure 3A (solid arrows, see Experimental Pro-
edures). By using this protocol, we found three fractions
i.e., fractions 8, 9, and 10) that generated a single VP1b
ragment (Figure 3B, top, lanes 3–5). Although Coomas-
ie staining identified approximately seven distinct pro-
ein bands in these fractions (Figure 3B, bottom), only
wo protein levels peaked within the fractions, one at
pproximately 29 kDa (**) and the other at 31 kDa (*).
To identify these two proteins, the 29 kDa and 31 kDa
ands in fraction eight were excised and subjected to
ass-spectrometry. The 29 kDa protein band was iden-
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291Figure 1. ER Activity Triggers a Conformational Change in Py
(A) Py (RA strain) was incubated with a control protein (bovine serum albumin, BSA) or a lumenal extract with or without DTT and/or EGTA
followed by trypsin addition. Samples were analyzed by SDS-PAGE and immunoblotted with VP1 antibody.
(B) As in (A) except the Py PTA strain was used.
(C) As in (A) except a lumenal extract derived from mouse (instead of dog) microsomes was used.
(D) Mass-spectrometry demonstrated that a C-terminal tryptic fragment (residues 353–368) in VP1 is absent in VP1b. Thus, the C-terminal
arm of VP1 is exposed by ER activity. The position of R352 is highlighted in the existing structure of Py VP1 pentamer (PDB number 1sid) to
pinpoint the region of the virus that likely is exposed.
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292Figure 2. ER Activity Is Heat-Labile and En-
ergy Independent
Py (RA) was incubated with BSA, a lumenal
extract (with or without heat inactivation), or
a cytosolic extract in the presence of DTT/
EGTA and ATP (where indicated), followed by
trypsin addition. Samples were analyzed as
in Figure 1. The lumenal and cytosolic ex-
tracts were immunoblotted with antibodies
against PDI and Hsp90.tified as ERp29 (Figure 3C, left), an ER-resident protein
that structurally belongs to the PDI family. An antibody
against rat ERp29 confirmed the identity of the 29 kDa
protein (Figure 3C, right). Mass-spectrometry did not
identify the 31 kDa band directly, and it was therefore
subjected to N-terminal sequencing. Sequence analy-
sis showed the first 10 amino acids of the 31 kDa pro-
tein to be similar to a predicted 31 kDa mammalian ER-
resident protein (Clissold and Bicknell, 2003). Because
the 31 kDa protein contains two thioredoxin domains,
it also belongs to the PDI family.
To determine whether ERp29 is required to trigger the
conformational change in Py virions, we immunode-
pleted ERp29 from the lumenal extract (Figure 4A, left
bottom panel, compare lane 2 to lane 3) and showed
that exposure of Py virions to the depleted extract did
not generate VP1b (Figure 4A, left top panel, compare
lane 2 to lane 3). To establish the specificity of this im-
munodepletion experiment, we immunodepleted PDI
and Ero1 (two ER factors previously shown to unfold
CT) from the extract (Figure 4A, right bottom panels)
and found that exposure to the depleted extracts gen-
erated VP1b to the same extent as exposure to the un-
treated extracts (Figure 4A, right top panel, compare
lanes 6 and 7 to lane 5). ERp29 is also required to trig-
ger the conformational change in particles of the Py
PTA strain (Figure 4B, compare lane 3 to lane 2). Thus,
ERp29 and/or associated factors expose the VP1 C-ter-
minal arm.
To determine if overexpression of ERp29 stimulates
activity, we transfected a construct encoding rat ERp29
into NIH 3T6 cells, harvested the extracts, and tested
them for the ability to generate the VP1b peptide. We
found a 3T6 cell extract overexpressing ERp29 (Figure
4C, second panel from top, compare lane 2 to lane 1)
enhanced the appearance of the VP1b fragment when
compared to a control cell extract (Figure 4C, top panel,
compare lane 2 to lane 1); the presence of a small
amount of VP1b in the control is likely due to endoge-
nous ERp29. The increased activity is not likely to come
from upregulation of other ER-resident factors, as the
level of PDI, ERp57, ERp72, and Bip did not increase in
the extract from ERp29 overexpressing cells (Figure 4C,
bottom four panels, compare lane 2 to lane 1). Neither
a bacteria extract containing ERp29 nor a purified, bac-
terially expressed, and His-tagged ERp29 protein alone
or in combination with an ERp29-depleted lumenal ex-
tract induced the formation of the VP1b peptide (Figure
4C, compare lane 5 to lane 4 and compare lanes 10 and

















































he p31 PDI-like protein (Figure 3C) did not increase
P1b formation compared to a control extract (not
hown). These data indicate that ERp29 is active when
xpressed in mammalian cells, but not in bacteria, and,
long with the immunodepletion data, establish ERp29
s a crucial factor that exposes the C-terminal arm of
P1.
Based on sequence analysis, ERp29 can be divided
nto an N-terminal thioredoxin domain (NTD) and a
-terminal domain (CTD), with the former shown to me-
iate homodimerization (Liepinsh et al., 2001). If the
Rp29 homodimer represents active ERp29, we rea-
oned that addition of ERp29 NTD may disrupt the
ctive form of ERp29 and inhibit its activity. To test this
ypothesis, we purified recombinant His-tagged ERp29
TD and CTD from bacteria (Figure 4D, lanes 1 and 2).
y themselves, neither the NTD nor the CTD generated
he VP1b fragment (Figure 4D, lanes 5 and 10). We
ound, however, that addition of ERp29 NTD to the lu-
enal extract inhibited the generation of VP1b (Figure
D, compare lane 7 to lane 6). As a control, addition of
Rp29 CTD to the lumenal extract did not prevent VP1b
ormation (Figure 4D, compare lane 12 to lane 11).
hese findings provide independent evidence for the
ole of ERp29 in mediating the conformational change
n polyoma virions and demonstrate that the ERp29
TD has a dominant-negative effect in the reaction.
Rp29 Stimulates Py to Bind Liposomes
e hypothesize that due to its large size, Py penetrates
irectly across the ER membrane lipid bilayer instead
f across a protein-conducting channel. To do so, the
irus would be rendered hydrophobic after experienc-
ng a conformational change in the ER, allowing it to
ind to the lumenal side of the ER membrane and to
nitiate transport of the virus particle into the cytosol.
e therefore tested whether the change triggered by
Rp29 causes Py virions to associate with liposomes.
y particles were first incubated with a lumenal extract
o induce the conformational change. Biotinylated lipo-
omes bound to Streptavidin-coated magnetic beads
ere added to the samples. Each sample was then
ransferred to a magnetic apparatus to sediment the
iposomes and any membrane bound materials. The
nbound material remained in the supernatant and was
eparated from the pelleted fraction. The amount of Py
n the pellet (i.e., virus that bound to the liposomes)
ersus the supernatant fraction (i.e., virus that did not
ind to the liposomes) was analyzed by sodium dode-
yl-sulfate-polyacrylamide gel electrophoresis (SDS-
Conformational Change of Polyomavirus by ERp29
293Figure 3. ER Activity Fractionation
(A) Based on initial studies, a strategy was developed to identify ER activity, with the expected activity fractionation pattern indicated by
solid arrows.
(B) (upper) The unbound lumenal proteins from Con A- and DEAE-Sepharose columns were bound to a Q-Sepharose column and eluted with
a continuous salt gradient. Activity in each fraction was analyzed as in Figure 1. Fractions (lower) were analyzed for their protein content by
reducing SDS-PAGE followed by Coomassie staining. Asterisk (*) indicates the 31 kDa protein and (**) indicates the 29 kDa protein.
(C) (left) The 29 and 31 kDa protein bands in fraction 8 were excised and subjected to mass-spectroscopy analysis or N-terminal sequencing,
respectively. The 29 kDa protein was identified as ERp29, an ER resident protein, whereas the 31 kDa protein is an uncharacterized ER-
resident thioredoxin-containing protein. An antibody (right) against rat ERp29 confirmed the identity of the 29 kDa protein.PAGE) followed by immunoblotting with a VP1 antibody
(Figure 5). Under these conditions, we found that in the
absence of liposomes, the VP1 protein of Py incubated
with either BSA or a lumenal extract remained in the
supernatant (Figure 5A, compare lane 1 to lane 2 and
lane 3 to lane 4). In the presence of liposomes, however,
a substantial portion of the VP1 incubated with a lume-
nal extract was in the pellet (Figure 5A, compare lane
8 to lane 7 and lane 6 to lane 5). The virus-liposome
interaction was resistant to high salt conditions (not
shown), suggesting that binding of Py to the membrane
is hydrophobic and not electrostatic. We conclude that
an ER activity stimulated the VP1 proteins to bind to alipid bilayer, presumably as a consequence of in-
creased particle hydrophobicity.
In addition to VP1, both the internal proteins VP2 and
VP3 were transferred to the liposomes after exposure
to a lumenal extract, but BSA was not (Figure 5B, com-
pare lane 4 to lane 2). These results suggest that the
entire virus binds liposomes. To determine whether the
membrane-associated virus is bound to the surface of
the liposomes or penetrates its interior, the samples
were treated with proteinase K. This treatment com-
pletely digested the liposome bound VP1, VP2, and VP3
(Figure 5B, lane 8). It is possible that the membrane-
associated virus penetrated the liposome and ruptured
Molecular Cell
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(A) (left) The ability of an ERp29-depleted extract to induce VP1b formation was analyzed as in Figure 1. Samples were also immunoblotted
with an antibody against ERp29. (Right) A PDI- and an Ero1-depleted extract were tested for their ability to induce VP1b formation. Samples
were also immunoblotted with an antibody against ERp29, PDI, and Ero1 (α/β).
(B) As in (A) except Py PTA strain was used in the reaction.
(C) (left) Nontransfected and ERp29-transfected 3T6 cell extracts were tested for activity. The levels of ERp29, PDI, ERp57, ERp72, and Bip
in the lysates were analyzed by immunoblotting with the appropriate antibodies. (Middle) Bacterial extract containing His-tagged ERp29 was
tested for activity. (Right) Purified bacterially expressed ERp29 incubated with or without an ERp29-depleted extract was tested for activity.
(D) (left) His-tagged ERp29 NTD and CTD were expressed in bacteria and purified. Asterisk (*) indicates an unidentified protein. (Middle) Py
was incubated with BSA, a lumenal extract, the NTD, a lumenal extract containing BSA, or a lumenal extract containing the NTD, and activity
was assessed as in Figure 1. (Right) As per the middle panel, except the CTD was used instead of the NTD.the membrane as a consequence, allowing proteinase
K to enter. To verify the integrity of the liposome, we
incorporated a His-tagged ERp29 protein into the lipo-
somes and tested ERp29’s resistance to proteinase K
digestion. In the absence of the lumenal extract and Py,
a partial degradation of the ERp29 protein was seen
(Figure 5B, compare lane 10 to lane 9), suggesting that









ome. Addition of Triton X-100 rendered the protease-
esistant species sensitive to degradation (Figure 5B,
ane 11), indicating that the liposome protected the
Rp29 protein. However, in the presence of Py and the
umenal extract, the liposome-incorporated ERp29 pro-
ein did not become more sensitive to protease diges-
ion (Figure 5B, compare lane 12 to lane 10), suggesting
hat the liposome remained intact in the presence of Py
Conformational Change of Polyomavirus by ERp29
295Figure 5. ERp29 Induces Py to Bind to Mem-
branes
(A) Py was incubated with BSA or a lumenal
extract followed by the addition of biotin-
ylated-liposomes (where indicated) bound to
Streptavidin-coated magnetic beads. Sam-
ples were transferred to a magnetic appara-
tus to separate the membrane bound (pellet)
from the membrane unbound (SN) fractions.
The samples were analyzed by SDS-PAGE
followed by immunoblotting with an anti-
body against VP1.
(B) (left) As in (A) except where indicated.
Samples were treated with proteinase K. The
samples were also immunoblotted with an
antibody against VP2/VP3. (Right) Lipo-
somes harboring His-tagged ERp29 were in-
cubated with either BSA or Py and a lumenal
extract. Samples were treated with protein-
ase K and Triton X-100 (where indicated) and
immunoblotted with an antibody against the
His-epitope.
(C) An ERp29-depleted extract was tested
for membrane binding activity.
(D) A 3T6 cell extract overexpressing ERp29
was compared to a control extract for mem-
brane binding activity.
(E) (left) Membrane binding activity of a virus
containing only the VP1 protein (VP1-VLP) is
compared to a wild-type (WT) Py. (right) The
ability of VP1-VLP to generate the VP1b frag-
ment was tested, as in Figure 1.and the lumenal extract. Therefore the sensitivity of the
membrane-associated virus to protease digestion re-
flects virus bound to the liposome surface, but not pen-
etrated into its interior, where the virus would be largely
protected from protease treatment.
We tested the ability of an ERp29-depleted extract
to induce liposome binding and found that an ERp29-
depleted extract caused substantially less VP1 to asso-
ciate with liposomes than did an untreated control (Fig-
ure 5C, compare lane 4 to lane 2), demonstrating that
ERp29 is required to induce Py virion binding. More-
over, treatment with an extract from cells overexpress-
ing ERp29 increased liposome association of virions
when compared to a control (Figure 5D, compare lane
4 to lane 2). These findings are consistent with the pro-
tease-digestion assay: an ERp29-depleted extract failed
to induce VP1b formation and membrane binding,
whereas a cell extract with overexpressed ERp29 stim-
ulated these reactions compared to a control extract.
Our data suggest that ERp29 renders Py virions hy-
drophobic, allowing the entire viral particle to bind to
the surface of the ER membrane; this step may prepare
the virus for penetration across the lipid bilayer.
Exposure of the hydrophobic surfaces of the internal
VP2 and VP3 proteins of Py or the VP2 myristic acid
may cause Py particles to bind liposomes and by infer-ence to associate with the lumenal membrane of the
ER. To test this possibility, we asked whether a virus-
like particle consisting of only the VP1, but not the VP2
and VP3, proteins (“VP1-VLP”) binds to the liposomes
after being exposed to a lumenal extract. We found that
in contrast to the wild-type Py, the VP1-VLP did not
bind to the liposome after incubation with a lumenal
extract (Figure 5E, compare lane 4 in left top and bot-
tom panels), even though the addition of the lumenal
extract to the VP1-VLP did generate the VP1b peptide
(Figure 5E, right panel, compare lane 2 to lane 1). The
observation that VP1-VLP does not bind to the lipo-
somes implicates VP2 and/or VP3 in membrane binding.
ERp29 Facilitates Py Infection in the Intact Cell
Our in vitro protease-digestion and membrane binding
assays suggest a role for ERp29 in the transport of Py
from the ER into the cytosol, a step that occurs before
the virus reaches the nucleus to replicate. To determine
whether ERp29 plays a role in Py infection, we asked
whether manipulating ERp29 activity affects viral infec-
tion. We monitored the expression of the virally encoded
VP1 protein, an event that follows viral DNA transcrip-
tion and replication in the nucleus, to assess Py infec-
tion efficiency.
To measure the appearance of newly synthesized
Molecular Cell
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2 hr, and the unbound virus was removed by washing
with media. The cells were either harvested immedi-
ately or allowed to incubate for an additional 46 hr be-
fore the cells were harvested. We detected VP1 in ly-
sates harvested at 48 hr, but not 2 hr, postinfection
(Figure 6A, compare lane 2 to lane 1). The absence of
VP1 in the 2 hr postinfection lysates indicates that the
level of virus that entered the cells within this time
frame is below the detection limit of the system. Hence,
the appearance of VP1 in the 48 hr postinfection lysates
represents newly synthesized VP1 and reflects suc-
cessful infection.
Because the ERp29 NTD inhibited the generation of
the VP1b fragment (Figure 4D), we asked whether ex-
pression of the NTD affects viral infection. The ER re-
tention sequence KEEL at the C terminus of ERp29 was
appended to the NTD (NTDKEEL) to facilitate NTD reten-
tion in the ER. A cDNA encoding ERp29 NTDKEEL was
transiently transfected into 3T6 cells for 48 hr, and the
cells were infected. Because Py arrives in the ER maxi-
mally 2–4 hr postinfection (Gilbert and Benjamin, 2004),
the cells were either harvested 2 hr postinfection to ex-
amine the NTDKEEL level or allowed to grow for an addi-
tional 46 hr to examine VP1 expression. In the 2 hr post-
infection lysate, we found the NTDKEEL and ERp29
levels to be similar in the NTDKEEL-transfected lysate
(Figure 6B, lane 2). At 48 hr postinfection, we found a
decreased VP1 level in the ERp29 NTDKEEL-transfected




























Figure 6. ERp29 Facilitates Py Infection
(A) 3T6 cells were incubated with Py for 2 hr, washed, and the cells were harvested or allowed to continue to grow for an additional 46 hr
and then harvested. The lysates were probed for the presence of VP1 and tubulin as a loading control.
(B) As in (A) except, where indicated, cells were transfected with either an empty vector, a cDNA encoding ERp29 NTDKEEL, or a cDNA
encoding HA-tagged calreticulin, prior to infection. An antibody against HA was used to detect the expression of calreticulin. Hsp90 level
was used as a loading control.
(C) FRTL-5 rat thyrocytes were transfected with either an empty vector or cDNA encoding ERp29 NTDKEEL. The levels of ERp29, NTD (lower),
and extracellular thyroglobulin (upper) were assessed by immunoblotting.ith an empty vector (Figure 6B, top panel, compare
ane 4 to lane 3). The lower NTDKEEL level when com-
ared to ERp29 is likely caused by dilution of the trans-
ected cDNA 48 hr postinfection (Figure 6B, bottom
anel, lane 4). As a control, overexpression of the hem-
gglutinin (HA)-tagged ER-resident protein, calreticulin
Figure 6B, middle panel, lane 6), did not decrease the
P1 level 48 hr postinfection (Figure 6B, top panel,
ompare lane 6 to lane 5).
Because ERp29 was initially found to mediate the
ecretion of thyroglobulin (Sargsyan et al., 2002), we
sked whether NTDKEEL overexpression also affects thy-
oglobulin secretion. Indeed, when the ERp29 NTDKEEL
as expressed in the FRTL-5 rat thyroid epithelial cells
Figure 6C, bottom panel, lane 2), the secreted thyroglo-
ulin level in the media decreased moderately (Figure
C, top panel, compare lane 2 to lane 1). These findings
ot only indicate that ERp29 NTD acts generally to in-
ibit endogenous ERp29 activity but, more importantly,
emonstrate that ERp29 facilitates Py infection.
iscussion
y travels from the plasma membrane to the ER from
hich it exits into the cytosol and then enters the nu-
leus to initiate infection. The physiological factor(s) in
he ER that cause Py to transport across the ER mem-
rane, as well as the molecular mechanism guiding this
embrane penetration process, were largely unknown.
ur results here identify an ER factor that induces a
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297conformational change in Py and provide mechanistic
insight into how Py may breach the ER membrane.
ERp29 Triggers a Conformational Change in Py
By using a protease digestion assay, we first show that
a conformational change is imparted upon Py by an
activity in an ER lumenal extract. Mass-spectrometry
demonstrated that the conformational change exposes
the C-terminal arm of VP1; whether the N terminus of
VP1 is exposed remains unclear. As the X-ray structure
of polyomavirus shows that the N-terminal region of
VP1 is close to the C-terminal invading arm of a neigh-
boring VP1 (Stehle et al., 1994), it is possible that
ERp29 also exposes that N-terminal region. Next, using
an unbiased biochemical fractionation approach, we
pinpointed ERp29, a structural homolog of PDI, as a
potential candidate for the activity. Immunodepletion of
ERp29 from the extract abolished activity, whereas
overexpression of ERp29 in mammalian cells stim-
ulated this reaction. Moreover, addition of ERp29’s
NTD, but not the CTD, to the extract inhibited activity.
These findings establish ERp29 as a crucial component
of ER activity that exposes the C-terminal arm of VP1.
Although not essential, the reductant DTT and the
calcium-chelator EGTA stimulated the ER-induced Py
conformational change. It is possible that DTT and
EGTA partially destabilized Py’s structure, enabling
ERp29 to subsequently expose VP1’s C-terminal arm
efficiently. This explanation is supported by previous
biochemical and X-ray structural studies showing that
disulfide bridges and calcium ions provide critical
structural support for Py (Brady et al., 1978; Stehle et
al., 1996). Because the disulfide bond in Py virions is in
proximity to the N terminus of VP1, its reduction may
enable ERp29 to also expose the VP1 N terminus. DTT
and EGTA likely mimicked the action of ER reductases
(e.g., PDI) and calcium binding proteins (e.g., calnexin
and calreticulin) that would normally act on the virus. In
fact, downregulation of PDI in cells was recently ob-
served to inhibit Py infection (J. Gilbert, W. Ou, J. Silver,
and T.B., unpublished data).
The molecular mechanism by which the NTD acts to
inhibit ERp29 activity is unclear. As the NTD mediates
ERp29 homodimerization (Liepinsh et al., 2001), the
NTD could disrupt the ERp29 homodimer through for-
mation of an NTD:ERp29 heterodimer and, as a conse-
quence, attenuate ERp29’s activity. Whether ERp29 is
sufficient to drive the Py conformational change re-
mains uncertain, as purified, bacterially expressed
ERp29 was inactive; the protein may be folded improp-
erly, lack a posttranslational modification, or require ad-
ditional ER factors to recapitulate the reaction. Further
experiments will clarify these possibilities.
ERp29 and Membrane Penetration of Py
We next examined how the ERp29-induced conforma-
tional change facilitates Py transport across the ER
membrane. Given its relatively large size (450 Å in diam-
eter), even a partially disassembled Py particle is un-
likely to transport across a protein-conducting channel
in the ER membrane. We therefore postulate that Py
penetrates the ER membrane by crossing the lipid bi-
layer directly. By using a liposome binding assay, weshowed that incubation of Py with an ER lumenal ex-
tract stimulated the entire viral particle to bind to lipo-
somes. This step presumably mimics binding of Py to
the lumenal side of the ER membrane in preparation for
its penetration across the bilayer. Similar to the prote-
ase digestion assay, we found that an ERp29-depleted
extract was unable to promote liposome binding,
whereas an extract from 3T6 cells overexpressing
ERp29 stimulated this response. Thus, in addition to
exposing the VP1 C-terminal arm, ERp29 also facili-
tates Py membrane binding.
Although the precise mechanism by which external-
ization of the VP1 C-terminal arm causes membrane
binding remains unknown, our data implicate the in-
volvement of Py’s internal proteins VP2 and VP3, be-
cause a VLP consisting of only the VP1 shell does not
bind liposomes. A possible scenario is that exposure of
the VP1 C-terminal arm leads to an expansion of the
central “pore” of the VP1 pentamer, enabling the VP2
myristic acid to emerge through the pore (Chen et al.,
1998); the resulting hydrophobic viral particle then
binds to the membranes. In fact, a mutant Py in which
the VP2 lacks the myristic acid was shown previously
to infect cells with 15-fold less efficiency, suggesting a
role of the VP2 myristic acid in viral infection (Sahli et
al., 1993).
ERp29-mediated externalization of the VP1 C-ter-
minal arm and possibly the VP2 myristic acid is remark-
ably similar to the mechanism by which receptor in-
teraction causes the nonenveloped poliovirus to bind
to membranes. Upon binding to its receptor, poliovirus
undergoes a conformational change accompanied by
externalization of VP4 (which is myristoylated at its N
terminus) and the N-terminal arm of VP1 (Fricks and
Hogle, 1990). In fact, early studies have already shown
that poliovirus binding to its receptor at the cell surface
causes VP4 to exit from the viral particle (Lonberg-
Holm et al., 1975; De Sena and Mandel, 1977). The
ERp29-Py interaction is also reminiscent of the interac-
tion between cellular proteases and the nonenveloped
reovirus: proteolytic processing of reovirus triggers the
exposure of the hydrophobic, N terminally myristoy-
lated 1N peptide, generating a hydrophobic particle
that allows it to bind and penetrate the late endosomal
membrane (Chandran and Nibert, 2003).
How the membrane-embedded Py reaches the cyto-
sol is unknown. The virus-membrane interaction could
induce holes in the bilayer by disrupting the phos-
pholipid organization, thereby enabling the virus to
“squeeze” through the holes. The “leakiness” of the ER
membrane (Le Gall et al., 2004) due to its low choles-
terol concentration may be a membrane property that
further facilitates Py’s penetration process. Spontane-
ous partitioning of the membrane-embedded hydro-
phobic virus into the aqueous cytosolic environment is
unfavorable energetically. Thus, it is conceivable that
cytosolic chaperones would bind to the exposed hy-
drophobic regions of Py on the cytosolic surface of the
ER membrane and extract the virus into the cytosol.
This situation is similar to the role of the cytosolic p97
ATPase in extracting misfolded ER proteins from the ER
membrane into the cytosol (Ye et al., 2001).
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To establish a functional role of ERp29 in Py infection,
we demonstrated that in the intact cell, overexpression
of the dominant-negative ERp29 NTD reduced the effi-
ciency of viral infection. This finding indicates that the
Py conformational change imparted by ERp29 is a criti-
cal event leading to successful viral infection.
PDI-Family Members: A General Class of ER
Remodeling Chaperones?
We previously demonstrated that PDI unfolds CT (Tsai
et al., 2001). Here, the PDI-like protein ERp29 is shown
to trigger a conformational change in Py. The striking
observation that PDI-like proteins mediate these reac-
tions implicates PDI family members as a general class
of ER remodeling chaperones.
It is unlikely that the remodeling activities displayed
by PDI and ERp29 are intended to mediate pathogen
entry, but more likely represent reactions crucial for nor-
mal cellular functions. For instance, unfolding events in
the ER initiate the translocation of misfolded proteins
from the ER to the cytosol for degradation by the pro-
teasome, a process called retrotranslocation (Tsai et al.,
2002). CT disguises itself as a misfolded substrate to
hijack this translocation process and reach the cytosol
(Hazes and Read, 1997). In fact, in addition to facilita-
ting CT retro-translocation, PDI has been shown to play
a similar role for misfolded ER substrates (Molinari et
al., 2002). The parallel cellular function of ERp29’s re-
modeling activity remains to be characterized.
What are the energy sources that drive both PDI and
ERp29’s remodeling reactions? PDI family members are
characterized by the presence of a thioredoxin domain
in their structures. Within this domain is the signature
CxxC motif that allows the protein to cycle between a
reduced and an oxidized state. In some cases, one of
the Cys residues is replaced by a different residue (e.g.,
CxxA). PDI has four thioredoxin domains, two of which
contain the CxxC motif. We found previously that PDI’s
redox states drive its unfolding activity (Tsai et al.,
2001): in its reduced state, PDI binds and unfolds the
toxin, whereas in its oxidized state, PDI releases it. That
PDI acts as a redox-driven chaperone was observed in
the retro-translocation of the membrane protein BACE457
(Molinari et al., 2002). Because ERp29 contains only a
single Cys residue in its entire sequence (Cys157), it
remains either in the reduced state or forms a mixed-
disulfide with another ER factor. Thus ERp29’s reduced
and mixed-disulfide bonded states may exhibit dif-
ferent conformations, enabling it to bind to substrates
with different affinities. Alternatively, noncovalent in-
teractions with other ER factors could change ERp29’s




Py and VP1 antibodies were provided by the Benjamin laboratory.
Antibodies against the VP2/VP3 proteins and the VP1 VLP were
generous gifts from Dr. Roberto Garcea (University of Colorado).
Monoclonal antibodies against rat ERp29 were produced by ASLA
BIOTECH Ltd. (Riga, Latvia). Polyclonal antibodies against rat thy-

































































icrosomes from dog pancreas were a generous gift from Dr. Tom
apoport (Harvard Medical School). Purified phospholipids were
urchased from Avanti.
ractionation of ER Lumenal Extract from Dog
ancreas Microsomes
n ER lumenal extract derived from dog pancreas microsomes was
repared as before (Tsai et al., 2001). The extract was bound to a
on A-Sepharose column and the flow-through was collected and
ound to the weak anion exchange DEAE-Sepharose column. Next,
he flow-through proteins from this column were bound to the
trong anion exchange Q-Sepharose column, and the bound pro-
eins were eluted from the column with an increasing salt gradient
50 mM to 1M potassium acetate). 0.5 ml fractions were collected,
ialyzed, and analyzed for both their protein content and their abil-
ty to generate the VP1b peptide.
reparation of a Cytosolic Extract
T6 cells were incubated with 0.025% digitonin for 10 min at 4°C
o selectively permeabilize the plasma membrane, but not internal
rganelle membranes (Le Gall et al., 2004). Cells were centrifuged
t 14,000 rpm for 10 min at 4°C to “squeeze” out the cytosolic
ontent. SDS-PAGE analysis followed by immunoblotting revealed
he cytosolic extract did not contain ER proteins (Figure 2).
rypsin Sensitivity Assay
y was incubated with or without DTT (3 mM) and EGTA (10 mM)
or 20 min at 37°C. BSA (1 mg/ml), a lumenal extract (1mg/ml), or a
ytosolic extract (1 mg/ml) was added to the sample and incubated
or 60 min at 37°C. Trypsin (0.25 mg/ml) was added to the samples
or 30 min at 4°C, and the reaction was stopped by the addition of
LCK (1 mM) for 10 min at 4°C. Samples were analyzed by reducing
DS-PAGE followed by immunoblotting with a VP1 antibody.
dentification of the VP1b Fragment
he VP1b fragment is generated by incubating Py in the presence
f DTT (3 mM), EGTA (10 mM), and a lumenal extract, followed
y trypsin addition (0.25 mg/ml). To facilitate isolation of the VP1b
ragment, we found that Py incubated in the presence of DTT (3 mM),
GTA (10 mM), and a higher concentration of trypsin (5 mg/ml) also
enerated the VP1b fragment. Full-length VP1 and VP1b fragments
ere excised from an SDS-PAGE gel and subjected to mass-
pectroscopy analysis. Results demonstrated that a tryptic-pep-
ide (VYDGTEPVPGDPDMTR) corresponding to residues 353–368
n VP1 is absent in VP1b, suggesting that VP1b represents residues
–352 of VP1. The position of residue R352 in the existing structure
f the Py VP1 pentamer (PDB number 1sid; Stehle et al., 1994) is
ighlighted in Figure 1D.
mmunodepletion of ERp29
0 l of an ER lumenal extract was incubated with an ERp29, a
DI, or an Ero1 antibody overnight at 4°C, followed by adding 20
l of protein A Sepharose beads.
eterologous Expression and Purification
f Rat ERp29 NTD and CTD
DNA fragments encoding ERp29 NTD (residues 33–154) and CTD
residues 155–260) were generated by PCR amplification and sub-
loned into pQE30. The constructs were transformed into BL21
. coli. Single colonies were picked and used to inoculate a 5 ml
B overnight culture. The culture was diluted into 500 ml LB and
rown to OD600 = 0.3. IPTG (1 mM) was added to the culture, which
as then allowed to grow for 2 hr. Cells were pelleted, resuspended
n a lysis buffer (150 mM KOAc, 250 mM sucrose, 50 mM HEPES
pH 7.5], 2 mM Mg(OAc)2, 1% Triton X-100, and protease inhibitors),
ounced, and sonicated. The cell debris was pelleted, and the re-
ulting supernatant containing NTD or CTD was purified by binding
o a Qiagen Ni-NTA Agarose column and elution with imidazole (150
M). The proteins were dialyzed and analyzed for purity by Coo-
assie staining.
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299Liposome Binding Assay
Biotinylated-liposome was made by mixing chloroform-dissolved
phosphatidyl-choline (80 g), -ethanolamine (25 g), -inositol (12.5
g), -serine (3 g), and biotinylated-phosphatidyl-ethanolamine (25
g). The mixture was dried, resuspended in a buffer (50 mM HEPES
[pH7.6], 250 mM sucrose, 150 mM KOAc, and 2 mM MgCl2) with or
without purified His-tagged ERp29 (5 g), and sonicated. Strepa-
vidin-coated magnetic beads were added to the liposomes and
transferred to a magnetic apparatus to pellet the biotinylated-lipo-
somes. To analyze Py binding, Py was incubated with the indicated
extract for 60 min at 37°C, then incubated with the biotinylated-
liposomes bound to Strepavidin-coated magnetic beads for 20 min
at 37°C and transferred to a magnetic apparatus to pellet the bio-
tinylated-liposomes and any membrane bound material. Both the
pellet and supernatant fractions were subjected to SDS-PAGE, fol-
lowed by immunoblotting with a VP1 or VP2/3 antibodies. Where
indicated, samples were treated with 0.1 mg/ml of proteinase K for
30 min at 4°C prior to SDS-PAGE analysis.
Infection Assay
NIH-3T6 cells were plated in 6-well dishes. Where indicated, cells
were transfected with a cDNA construct encoding rat ERp29
NTDKEEL(pcDNA3.1-ERp29NTDKEEL). The ERp29 NTDKEEL construct
was generated by appending ERp29’s KEEL sequence to residue
M154 of the NTD. 48 hr posttransfection, cells were washed and
infected with Py. After 2 hr, the cells were washed to remove extra-
cellular virus and either harvested or allowed to incubate for 46
additional hrs at which point the cells were harvested. Cells were
lysed, subjected to SDS-PAGE, and immunoblotted with antibodies
against VP1, ERp29, an HA-epitope, Hsp90, or tubulin.
Thyroglobulin Secretion
FRTL-5 rat thyrocytes were transfected with pcDNA3.1-
ERp29NTDKEEL. 48 hr after transfection, the medium was collected,
centrifuged for 20 min at 17,000 × g, and the supernatant was ana-
lyzed for the presence of thyroglobulin. Cells were lysed, centri-
fuged for 10 min at 17,000 × g, and the supernatant was analyzed
for the presence of ERp29 and NTD.
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